Clinical Trial Update: Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Lactobacillus-reuteri probiotics with antibiotics therapy in smoker subjects with periodontal disease; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Diseases
• Smoking

Drugs mentioned

• Lactobacillus-reuteri probiotics (Lactobacillus reuteri)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Periodontal Diseases, Smoking | Phase 3 | Status: COMPLETED